Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pradeep S Virdee

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
International Journal of Cancer|December 17, 2019
Quality of life in the FOXFIRE, SIRFLOX and FOXFIRE-global randomised trials of selective internal radiotherapy for metastatic colorectal cancerJane Wolstenholme, Francesco Fusco, Alastair M Gray, et al.
Physics and Imaging in Radiation Oncology|August 27, 2024
Diffusion-weighted magnetic resonance imaging as an early prognostic marker of chemoradiotherapy response in squamous cell carcinoma of the anus: An individual patient data <i>meta</i>-analysisBettina A Hanekamp, Pradeep S Virdee, Vicky Goh, et al.
JMIR Cancer|June 27, 2025
Clinical Prediction Models Incorporating Blood Test Trend for Cancer Detection: Systematic Review, Meta-Analysis, and Critical AppraisalPradeep S Virdee, Kiana K Collins, Claire Friedemann Smith, et al.
The Lancet Regional Health. Europe|June 8, 2026
Diagnostic Implications of Multi-Cancer Early Detection Testing in the Investigation of Cancer Symptoms: An Exploratory Retrospective Analysis of the SYMPLIFY StudyAshley Jackson, Pradeep S Virdee, Sharon Tonner, et al.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2019
Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinomaAnne Thomas, Pradeep S Virdee, Martin Eatock, et al.
Cancers|May 11, 2024
The Association between Blood Test Trends and Undiagnosed Cancer: A Systematic Review and Critical AppraisalPradeep S Virdee, Kiana K Collins, Claire Friedemann Smith, et al.
BMC Cancer|February 6, 2019
Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2)Victoria Y Strauss, Rachel Shaw, Pradeep S Virdee, et al.
Diagnostic and Prognostic Research|January 9, 2023
BLOod Test Trend for cancEr Detection (BLOTTED): protocol for an observational and prediction model development study using English primary care electronic health record dataPradeep S Virdee, Clare Bankhead, Constantinos Koshiaris, et al.
The Lancet. Oncology|October 12, 2024
Validity and timeliness of cancer diagnosis data collected during a prospective cohort study and reported by the English and Welsh cancer registries: a retrospective, comparative analysisAshley Jackson, Pradeep S Virdee, Sharon Tonner, et al.
The Lancet. Oncology|August 8, 2017
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trialsHarpreet S Wasan, Peter Gibbs, Navesh K Sharma, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
International Journal of Cancer|December 17, 2019
Quality of life in the FOXFIRE, SIRFLOX and FOXFIRE-global randomised trials of selective internal radiotherapy for metastatic colorectal cancerJane Wolstenholme, Francesco Fusco, Alastair M Gray, et al.
Physics and Imaging in Radiation Oncology|August 27, 2024
Diffusion-weighted magnetic resonance imaging as an early prognostic marker of chemoradiotherapy response in squamous cell carcinoma of the anus: An individual patient data <i>meta</i>-analysisBettina A Hanekamp, Pradeep S Virdee, Vicky Goh, et al.
JMIR Cancer|June 27, 2025
Clinical Prediction Models Incorporating Blood Test Trend for Cancer Detection: Systematic Review, Meta-Analysis, and Critical AppraisalPradeep S Virdee, Kiana K Collins, Claire Friedemann Smith, et al.
The Lancet Regional Health. Europe|June 8, 2026
Diagnostic Implications of Multi-Cancer Early Detection Testing in the Investigation of Cancer Symptoms: An Exploratory Retrospective Analysis of the SYMPLIFY StudyAshley Jackson, Pradeep S Virdee, Sharon Tonner, et al.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2019
Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinomaAnne Thomas, Pradeep S Virdee, Martin Eatock, et al.
Cancers|May 11, 2024
The Association between Blood Test Trends and Undiagnosed Cancer: A Systematic Review and Critical AppraisalPradeep S Virdee, Kiana K Collins, Claire Friedemann Smith, et al.
BMC Cancer|February 6, 2019
Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2)Victoria Y Strauss, Rachel Shaw, Pradeep S Virdee, et al.
Diagnostic and Prognostic Research|January 9, 2023
BLOod Test Trend for cancEr Detection (BLOTTED): protocol for an observational and prediction model development study using English primary care electronic health record dataPradeep S Virdee, Clare Bankhead, Constantinos Koshiaris, et al.
The Lancet. Oncology|October 12, 2024
Validity and timeliness of cancer diagnosis data collected during a prospective cohort study and reported by the English and Welsh cancer registries: a retrospective, comparative analysisAshley Jackson, Pradeep S Virdee, Sharon Tonner, et al.
The Lancet. Oncology|August 8, 2017
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trialsHarpreet S Wasan, Peter Gibbs, Navesh K Sharma, et al.
Pageof 3